Cited 0 time in
A Case of Recurrent Meningitis Caused by Rhodococcus species Successfully Treated with Antibiotic Treatment and Intrathecal Injection of Vancomycin through an Ommaya Reservoir
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Kanglok | - |
| dc.contributor.author | Rho, Min | - |
| dc.contributor.author | Yu, Miyeon | - |
| dc.contributor.author | Kwak, Joohee | - |
| dc.contributor.author | Hong, Seungpyo | - |
| dc.contributor.author | Kim, Jisoong | - |
| dc.contributor.author | Kim, Yeonjae | - |
| dc.contributor.author | Pai, Hyunjoo | - |
| dc.date.accessioned | 2022-07-15T21:08:59Z | - |
| dc.date.available | 2022-07-15T21:08:59Z | - |
| dc.date.issued | 2015-09 | - |
| dc.identifier.issn | 2093-2340 | - |
| dc.identifier.issn | 2092-6448 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/156455 | - |
| dc.description.abstract | Human infection by Rhodococcus species is rare and mostly limited to immunocompromised hosts such as patients infected with the human immunodeficiency virus (HIV) or organ transplant recipients. The most common strain is R. equi, and the most common clinical presentation is pulmonary infection, reported in 80% of Rhodococcus spp. infections. The central nervous system is an uncommon infection site. We report a case of a patient with pneumonia, brain abscess, and recurrent meningitis caused by Rhodococcus spp. He initially presented with pneumonia with necrosis, which progressed to brain abscess and recurrent meningitis. Rhodococcus spp. was identified from the cerobrospinal fluid (CSF) collected during his fourth hospital admission. Despite prolonged treatment with appropriate antibiotics, meningitis recurred three times. Finally, in order to administer antibiotics directly into the CSF and bypass the blood-brain barrier, an Ommaya reservoir was inserted for administration of 90 days of intrathecal vancomycin and amikacin in conjunction with intravenous and oral antibiotics; the patient was finally cured with this treatment regimen. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy | - |
| dc.title | A Case of Recurrent Meningitis Caused by Rhodococcus species Successfully Treated with Antibiotic Treatment and Intrathecal Injection of Vancomycin through an Ommaya Reservoir | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.3947/ic.2015.47.3.183 | - |
| dc.identifier.scopusid | 2-s2.0-84945538671 | - |
| dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.47, no.3, pp 183 - 189 | - |
| dc.citation.title | Infection and Chemotherapy | - |
| dc.citation.volume | 47 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 183 | - |
| dc.citation.endPage | 189 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART002034481 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordPlus | amikacin | - |
| dc.subject.keywordPlus | antibiotic agent | - |
| dc.subject.keywordPlus | ceftriaxone | - |
| dc.subject.keywordPlus | clindamycin | - |
| dc.subject.keywordPlus | cotrimoxazole | - |
| dc.subject.keywordPlus | doxycycline | - |
| dc.subject.keywordPlus | imipenem | - |
| dc.subject.keywordPlus | levofloxacin | - |
| dc.subject.keywordPlus | linezolid | - |
| dc.subject.keywordPlus | meropenem | - |
| dc.subject.keywordPlus | moxifloxacin | - |
| dc.subject.keywordPlus | rifampicin | - |
| dc.subject.keywordPlus | roxithromycin | - |
| dc.subject.keywordPlus | sulfamethoxazole | - |
| dc.subject.keywordPlus | teicoplanin | - |
| dc.subject.keywordPlus | vancomycin | - |
| dc.subject.keywordPlus | adult | - |
| dc.subject.keywordPlus | antibiotic therapy | - |
| dc.subject.keywordPlus | Article | - |
| dc.subject.keywordPlus | bacterial pneumonia | - |
| dc.subject.keywordPlus | blood brain barrier | - |
| dc.subject.keywordPlus | blood culture | - |
| dc.subject.keywordPlus | brain abscess | - |
| dc.subject.keywordPlus | case report | - |
| dc.subject.keywordPlus | cerebrospinal fluid | - |
| dc.subject.keywordPlus | cerebrospinal fluid culture | - |
| dc.subject.keywordPlus | computer assisted tomography | - |
| dc.subject.keywordPlus | disease course | - |
| dc.subject.keywordPlus | drug treatment failure | - |
| dc.subject.keywordPlus | drug withdrawal | - |
| dc.subject.keywordPlus | emergency ward | - |
| dc.subject.keywordPlus | hospitalization | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | human tissue | - |
| dc.subject.keywordPlus | lung lavage | - |
| dc.subject.keywordPlus | male | - |
| dc.subject.keywordPlus | meningitis | - |
| dc.subject.keywordPlus | middle aged | - |
| dc.subject.keywordPlus | necrosis | - |
| dc.subject.keywordPlus | neutropenia | - |
| dc.subject.keywordPlus | nuclear magnetic resonance imaging | - |
| dc.subject.keywordPlus | Ommaya reservoir | - |
| dc.subject.keywordPlus | paresthesia | - |
| dc.subject.keywordPlus | physical examination | - |
| dc.subject.keywordPlus | pneumonia | - |
| dc.subject.keywordPlus | remission | - |
| dc.subject.keywordPlus | Rhodococcus | - |
| dc.subject.keywordPlus | sepsis | - |
| dc.subject.keywordPlus | treatment duration | - |
| dc.subject.keywordPlus | treatment outcome | - |
| dc.subject.keywordPlus | unspecified side effect | - |
| dc.subject.keywordAuthor | Rhodococcus species | - |
| dc.subject.keywordAuthor | Recurrent meningitis | - |
| dc.subject.keywordAuthor | Ommaya reservoir | - |
| dc.subject.keywordAuthor | Vancomycin | - |
| dc.identifier.url | https://icjournal.org/DOIx.php?id=10.3947/ic.2015.47.3.183 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
